Weble Dr Franck Zal crée la société Hemarina en 2007 laboratoire biopharmaceutique spécialisé dans le développement de produits de santé reposant sur les propriétés de l’hémoglobine du ver marin arénicole. Il est l’auteur de plusieurs dizaines de brevets internationaux, de plus de 100 publi- Web#Hemarina technology plateform is also a… Tissue engineering (TE) has become a new effective solution to a variety of medical problems, including diabetes. Franck Zal on …
Franck Zal on LinkedIn: #Hemarina #HEMO2life #OXYOP2
WebFranck Zal’s Post. Franck Zal 16h · Edited Report this post ... #Hemarina is currently developing a new device named #HemDentalCare using his patented technology … WebFranck Zal Eric Delpy Jonathan Jahr Oxygen is indispensable for the existence and maintenance of life as it is vital for life-sustaining aerobic respiration in Humans. Hemoglobin is the molecule... ccrt medical abbreviation kidney
Therapeutic Potential of Hemoglobin Derived from the …
WebAug 24, 2024 · HEMOXCell® produced by HEMARINA (Morlaix-France) is an oxygen carrier (molecule with high oxygen affinity) able to distribute oxygen according to the oxygen demand of the cells based on a PO2... WebMay 11, 2024 · De la découverte d’une molécule au CNRS au développement d'un produit aux services des patients dans le cadre des transplantations. L’aventure d’Hemarina, racontée par Franck Zal, son PDG et... WebApr 21, 2010 · Date of Patent: November 6, 2024 Assignee: HEMARINA Inventor: Frank Zal BIOREACTOR USING OXYGEN-CARRYING MOLECULES Publication number: 20120040453 Abstract: The present invention relates to devices and bioreactors capable of delivering oxygen to a cell culture using oxygen-carrying molecules. butch baby maternity